par Bedard, Philippe L;Piccart-Gebhart, Martine 
Référence Clinical breast cancer, 8, 4, page (157-165)
Publication Publié, 2008-12
Référence Clinical breast cancer, 8, 4, page (157-165)
Publication Publié, 2008-12
Article révisé par les pairs
| Titre: |
|
| Auteur: | Bedard, Philippe L; Piccart-Gebhart, Martine |
| Informations sur la publication: | Clinical breast cancer, 8, 4, page (157-165) |
| Statut de publication: | Publié, 2008-12 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Adjuvant chemotherapy |
| Bevacizumab | |
| Cardiac toxicity | |
| Lapatinib | |
| Trastuzumab | |
| MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
| Antineoplastic Agents -- therapeutic use | |
| Breast Neoplasms -- drug therapy | |
| Breast Neoplasms -- secondary | |
| Female | |
| Humans | |
| Lymphatic Metastasis | |
| Randomized Controlled Trials as Topic | |
| Receptor, erbB-2 -- antagonists & inhibitors | |
| Receptor, erbB-2 -- immunology | |
| Receptor, erbB-2 -- metabolism | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1526-8209 |
| info:doi/10.3816/CBC.2008.s.012 | |
| info:pii/48435800603N2485 | |
| info:scp/60849094827 | |
| info:pmid/19158036 |
